(Q34025083)

English

Combination mTOR and IGF-1R inhibition: phase I trial of everolimus and figitumumab in patients with advanced sarcomas and other solid tumors

scientific article

Statements

Combination mTOR and IGF-1R inhibition: phase I trial of everolimus and figitumumab in patients with advanced sarcomas and other solid tumors (English)
0 references
0 references
Richard Quek
Jeffrey A Morgan
Geoffrey I Shapiro
James E Butrynski
Nikhil Ramaiya
Tarsha Huftalen
Nicole Jederlinic
Judith Manola
Andrew J Wagner
Suzanne George
22 December 2010

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit